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GENERAL INTRODUCTION 
Since the beginning of time, man has utiUzed alkaloids as medicines. 
The term alkaloid or "alkali-like" is used to describe nitrogen-containing 
compounds of plant origin. Most of these compounds have complex molecular 
structures, and possess significant pharmacological activities. Huperzine A 
is a new lycopodium alkaloid extracted from Huperzia serrata, a club moss in 
China. It has been employed as a traditional medicine in China for the 
improvement of memory in the elderly. Because of its ability to enhance 
memory, it has attracted considerable interest as a potential treatment for 
Alzheimer's disease. 
As a consequence of the promise of huperzine A as a nootropic agent for 
the use in Alzheimer's disease, there is considerable interest in synthesizing 
this molecule and improved analogs for pharmacological testing. Previously, 
two syntheses of huperzine A have been reported. However, both routes offer 
low yields and similar strategies. 
The goal of this research was to s3aithesize huperzine A and analogs of 
huperzine A. An extremely efficient synthetic pathway has been devised. In 
addition, a convergent route to functionalized pyridones, structural subunits 
of huperzine A, has been developed which offers flexibility and a convenient 
route to improved analogs. This research will not only help to identify a 
region of the huperzine skeleton which may offer improved activity, but it will 
also make available multigram quantities of these useful compounds. 
2 
Explanation of Dissertation Format 
This dissertation is composed of two papers preceded by an introduction 
to huperzine A and a review of some previous synthetic routes to huperzine A. 
The second and third sections contain published and publishable articles, 
respectively. The first paper, published in Synthetic Communications, 
describes an efficient synthesis of huperzine A. The second paper outlines a 
route to functionalized pyridones, structural subunits of huperzine A. 
Following the second paper is a general conclusions chapter. 
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INTRODUCTION TO HUPERZINE A 
Huperzine A (1) and a related isomer huperzine B (2) were first isolated 
and characterized by Liu in 1986.1 The two new Lycopodium alkaloids were 
extracted from Huperzia serrata (Thunb.) Trev., a club moss found in China. 
The structures of 1 and 2 were determined by spectroscopic studies (Figure 1) 
10 
1 2 
Figure 1. Huperzine A (1) and huperzine B (2) are two 
alkaloids isolated from the extracts of a Chinese club 
moss and used in Chinese folklore medicine. 
Both of these alkaloids have been found to exhibit potent anticholin­
esterase activity. The negative logarithm of the molar concentration causing 
50% inhibition of cholinesterase, p/50, of huperzine A when measured on 
erythrocyte membrane acetylcholinesterase was 7.2; the p/50 of huperzine B 
when measured under the same conditions was 6.1.2 Therefore, huperzine A 
is more potent than huperzine B. Furthermore, it was determined that 
huperzine A has an antiacetylcholinesterase effect approximately three-fold 
that of physostigmine, another acetylcholinesterase inhibitor. The p/50 of 
physostigmine measured on erythrocyte membrane acetylcholinesterase was 
In a recent report by doctors at the Walter Reed Army Institute of 
Research, it was noted that huperzine A inhibited acetylcholinesterase in a 
16 
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Figure 2. The ratio koff/kon is the dissociation constant ki of 
the enzyme-inhibitor complex. Huperzine A was 
reported to inhibit AChE in a time-dependent 
manner (ki = 1 x 10® M"1 min'l). The inhibitor-
enzyme constant dissociated slowly (to.5 = 35 min). 
time-dependent manner and that the inhibitor-enzyme complex dissociated 
slowly. Physostigmine, however, has a rapid on-and-off rate (Figure 2).3 
Kozikowski measured the IC50 (concentration that inhibited 50% of the 
acetylcholinesterase activity) of S3nithetic (±)-huperzine A and compared this 
result to natural (-)-huperzine AA He found that synthetic (±)-huperzine A 
was one-half as potent as (-)-huperzine A. This would be expected as racemic 
huperzine A contains an equal quantity of the inactive (+) isomer. 
Because huperzine A possesses anticholinesterase activity, it is 
considered to be a potential treatment for Alzheimer's disease. In Alzheimer's 
disease, there is a significant decline in the function of cholinergic neurons in 
the brain and a resulting decrease in the quantity of acetylcholine.^ 
Acetylcholinesterase is the enzyme that breaks down acetylcholine into 
acetate and choline. Therefore, a possible therapeutic approach to 
Alzheimer's disease may be to compensate for the loss of cholinergic neurons 
by increasing the activity of the remaining cells with acetylcholinesterase 
inhibitors. 
Kozikowski has suggested that the heteroatoms of acetylcholine in its 
extended conformation overlay well with the heteroatoms of huperzine A 
(Figure 3).4 This extended conformation is believed to be the one which is 
operative during hydrolysis. The amino group of huperzine A should be 
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Figure 3. Huperzine A and physostigmine are two 
acetylcholinesterase inhibitors. Acetylcholine is the 
neurotransmitter that is hydrolyzed by the enzyme 
AChE. An overlay of huperzine A and the extended 
form of acetylcholine is shown. 
protonated at physiological pH, and is thus similar to the MeaN^ group of 
acetylcholine. 
Quinn et al. have described the acetylcholinesterase-inhibitor complex.® 
The enzyme is an ellipsoid with dimensions 65 x 55 x 40 A. In its middle is a 
20 A deep hydrophobic cleft which contains a hydrogen-bonded triad at the 
bottom that consists of the side chains of S200, H440 and E327. This triad 
functions as an acid-base unit to split the ester bond of acetylcholine.'^ In a 
model of the tetrahedral intermediate involved in the mechanism of 
acetylcholinesterase, the residue, S200, is joined to the carbonyl carbon of 
acetylcholine. The side chain of E199 is situated about 4.9 A from S200. This 
6 
side chain interacts with the quarternary ammonium moiety of acetylchohne. 
The carbonyl oxyanion of the acetylchohne tetrahedral intermediate is 
stabihzed by hydrogen bonding to the peptide NH residues. These residues 
form an oxyanion hole (Figure 4). 
The distance between the pyridone and exocyclic amino moieties in 
huperzine A closely resemble the 5 A distance in acetylcholinesterase 
between the oxyanion hole and the carboxylate side chain of El99. The 
similarity between huperzine A and the enzyme, as well as the similarity 
between huperzine A and acetylcholine (Figure 3) suggest that huperzine A is 
a constrained analog. Consequently, an improved analog of huperzine A 
might be one in which the pyridone to amine distance is no longer 
constrained. For example, a more flexible amino-substituted p5a-idone may 
possess enhanced acetylcholinesterase inhibitory activity (Figure 5). 
As a slow, reversible inhibitor of acetylcholinesterase that crosses the 
blood-brain barrier, huperzine A has been demonstrated to be superior for its 
anti-cholinesterase potency.® Consequently, investigators have suggested 
that huperzine A might be superior to other anti-cholinesterase drugs for the 
management of memory impairment associated with Alzheimer's disease. 
Recently, Grunwald et al. have reported that huperzine A may provide a safe 
treatment against nerve agent toxicity.^ 
To date, a number of analogs of huperzine A have been prepared. 
However, none of these compounds have shown acetylcholinesterase 
inhibitory activity rivaling that of huperzine A. From the above described 
studies, it is evident that structural modifications might leave the 
heteroaromatic ring and the bridgehead amine intact. In addition, huperzine 
Figure 4. A model of the tetrahedral intermediate involved in the catalytic mechanism of 
acetylcholinesterase is shown. The model demonstrates several important 
contacts between the enz3ane and the substrate. The carbonyl oxyanion of the 
acetylcholine intermediate is stabilized by hydrogen bonding to the peptide amino 
residues. The side chains of several residues (F288, F290, F331, and W233) form a 
hydrophobic nest in which the acyl methyl group of acetylcholine is located. 
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Figure 5. Disconnection of the bond between C13 and C4 may 
provide an analog of huperzine A with enhanced 
acetylcholinesterase activity 
A is much more potent than its related natural product huperzine B. This 
implies that not only the primary amine, but also the exocyclic alkene may be 
important moieties necessary for biological activity. 
Although, structural modifications to produce improved analogs are 
important, clearly an efficient synthesis of huperzine A is the primary goal. 
Two previous syntheses of huperzine A have been reported. Both the Qian 
and Ji synthesis!® and the Kozikowski s5aithesisll followed similar routes. 
The Qian and Ji s3mthesis started with the p-keto ester (3) which they 
prepared from 5-ethoxycarbonyl-6-methyl-2-p3n'idone in several steps (39% 
yield). The P-keto ester (3) was treated with methacrolein in methanol to give 
the cyclic ketol. The ketol was dehydrated by mesylation, followed by 
elimination of the resulting mesylate to the olefin. Wittig reaction with 
ethylidenetriphenylphosphorane gave (4) as a mixture of Z and E isomers. 
The mixture was treated with KOH in methanol which preferentially 
hydrolyzed the E-isomer. The corresponding acid was then converted into the 
urethane using a modified Curtius reaction. Cleavage of the methyl ether 
and hydrolysis of the urethane to the amine gave racemic huperzine A 
(Scheme I). 
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Scheme 1 
HO 
1) , MeOH N^OMe 
2) MsCl, NaOAc 
3) Ph3P=CHCH3 COgMe 
O OEt 
3 
1) KOH-MeOH 
2) (PhO)2PON3 
H 
.0 
4 
3) MegSiCl, Nal, CHgCN 
4) KOH 
NHg 
This synthesis produced huperzine A in 0.18% overall yield. The 
olefination step gave the incorrect isomer as the major product (5:95, E:Z) 
which was not isomerized to the correct isomer. This tremendously hurt the 
overall yield of the synthesis. Furthermore, the starting material, which is 
the same starting material used in the Kozikowski synthesis, is difficult to 
synthesize and offers at best a 39% yield. A more simplified route starting 
from readily available materials would offer many advantages toward the 
synthesis of huperzine A. 
The Kozikowski synthesis began with Ji's p-keto ester (3) which he 
prepared in seven steps (27% yield) from the monoethylene-ketal of 
1,4-cyclohexanedione. The reaction of the P-keto ester (3) with methacrolein 
using tetramethylguanidine (TMG) gave the cyclic ketol by a Michael/aldol 
process. Again, dehydration, followed by Wittig olefination with 
ethylidenetriphenylphosphorane gave the (Z)- and (E)-alkenes (4). However, 
Kozikowski isomerized the incorrect isomer by treating the mixture with 
AIBN and thiophenol. The last operations offered no surprises, conversion of 
11 
the ester group to the amino group by a Curtius rearrangement and cleavage 
of the 0-methylether to the pyridone ring. (±)-Huperzine A was obtained in a 
3% overall yield (Scheme II). 
Scheme II 
OH 
, TMG ^^v^N^OMe 
^'O OEt 
2) MsCl, NaOAc 
3) Ph3P=CHCH3 
C02Me 
4 
1) PhSH, AIBN 
2) NaOH, MeOH 
3) SOCI2 
4) NaNg; MeOH If 
5) TMSI 
This strategy contained several steps and offered a modest yield. The 
dehydration of the alcohol to form the endocyclic alkene proceeded in low 
yield. 
Recently, Kozikowski has reported an improved synthesis of huperzine A. 
The key step involved a palladium-catalyzed alkylation of a bifunctional 
alkylating agent, 5, with the p-keto ester 3, to give 6 in 92% yield. Treatment 
with triflic acid in dioxane gave the isomerized product, 7, in a 90% yield. The 
rest of the synthesis followed that previously reported (Scheme III). 
This route significantly improved the yield because it omitted the 
dehydration step to the endocyclic olefin which at best gave a 31% yield. In 
this report, he also synthesized two analogs (9 and 12) which were tested for 
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Scheme III 
OCH3 Ac oJL' OAc 
pdcoAc:^, pph3, 
TMG 
^"0 OEt 
TfOH 
COoMe 
1) Ph3P=CHCH3 
2) PhSH, AIBN 
OMe 3) NaOH, MeOH 
4) SOCfe 
5) NaNa; MeOH W 
6) TMSI 
C02Me 
NHa 
their ability to inhibit acetylcholinesterase enzyme from rat cortex (Scheme 
IV). 
By treatment of 8 with lithium n-propanethiolate in HMPA, he obtained 
the unrearranged aminopyridone, methylene analog 9. This analog tested 
less potent than huperzine A, with an IC50 of 4.9 ± 1.5 [xmol dn-3. 
In order to sjTithesize the diamino analog 12, the methylene 
intermediate 6 was reacted with osmium tetroxide-sodium periodate to 
produce the diketone which was selectively transformed to the monoethylene 
ketal, 10. Then, the ethylidene group was installed, the ester was hydrolyzed 
to the acid, and the acid was converted to the urethane, 11, by the usual 
Curtius rearrangement. Ketal hydrolysis, reductive amination and 
deprotection, resulted in the diamino analog, 12. Analog 12 had an IC50 value 
of 8.1 ± 1.3 lamol dn"3, which means it had an activity 110 times less active 
than huperzine A. 
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Scheme IV 
NHCOgMe 
8 
OMe 
/i-PrSLi^ 
HMPA 
9 
6 
1) Ph3P=CHCH3 
2) PhSH, AIBN 
3) NaOH, MeOH ^ 
4) (PhO)2PON3; MeOH Y ^ 
rT^o 
1) OSO4; NaI04 
2) ethylene glycol 
COgMe 
10 
1) Ph3P=CHCH3 
2) PhSH, AIBN 
3) NaOH, MeOH 
4) (PhO)2PON3; MeOH 
NH, 
NHCOgMe 
11 
1) 5% HCl, i-PrOH 
OMe 2) NH3, NH4CI; NaBH4 
3) TMSI 
12 
These results may suggest that the endocyclic double bond in the bridged 
system may be important for its biological activity. Quinn has suggested that 
modeling shows a jr-7t interaction between huperzine A and aromatic 
residues of the enz3ane.6 What effect does the double bond have and is the 
methyl substituent important for biological activity? 
14 
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PAPER I: A BRIDGEHEAD ENONE APPROACH TO HUPERZINE A 
Published by Synthetic Communications 1992,22, 2625-2634 
George A. Kraus, Jeff Hansen, and Danette Vines 
Department of Chemistry, Iowa State University, Ames, lA 50011 
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BACKGROUND 
Huperzine A has recently attracted considerable interest as a target for 
the synthetic chemist. It was first isolated from Lycopodium serratum and 
characterized by Liu in 1986.1 Huperzine A is a potent nootropic agent.2 In 
other words, it has the ability to improve memory. Huperzine A is one of the 
most potent reversible inhibitors of acetylcholinesterase.3 In the cholinergic 
system, acetylcholinesterase is the enzyme responsible for the breakdown of 
acetylcholine to choline and acetate ion. In Alzheimer's disease, a deficiency 
in the quantity of acetylcholine in the brain is observed. The cholinergic 
neurons degenerate and it is believed that memory impairment is due to this 
decrease in cholinergic neurotransmission. The use of reversible inhibitors of 
acetylcholinesterase, therefore, is considered to be a viable therapeutic 
approach to the disease. The acetylcholinesterase inhibitor, physostigmine, 
has been limited by its short duration of action. Recently, tacrine (tetrahy-
droaminoacridine) has been approved by the FDA as a treatment for 
Alzheimer's disease. This acetylcholinesterase inhibitor, however, has toxic 
side effects, such as hepatotoxicity. Huperzine A has demonstrated 
superiority to both physostigmine and tacrine. Not only does it have fewer 
side effects than other inhibitors, but it also has a longer duration of action. 
Consequently, huperzine A has attracted considerable interest as a 
treatment for Alzheimer's disease (Figure 1). 
Kozikowski has suggested that the activity of huperzine A is due to the 
similarity in the arrangement of its heteroatoms to the heteroatoms in the 
completely extended conformation of acetylcholine.^ Huperzine B (2) and 
Z-huperzine A (3), two related natural products, are both less active than 
18 
NH, 
"O 
Huperzine A Physostigmine Tacrine 
Figure 1. The structures of huperzine A, physostigmine, and 
tacrine are shown. All are potent 
acetylcholinesterase inhibitors. 
huperzine A (1). This implies that the primary amine and the exocyclic 
alkene moieties might best be left intact when structural modifications are 
designed (Figure 2).^ 
Two previous syntheses of huperzine A have been accomplished. Both 
the Ji synthesis^ (path a) and the Kozikowski synthesis (path b) of huperzine 
and selected analogs'^ followed the same strategy (Scheme I). Recently, 
Huperzine B 
(2) 
NH, 
Huperzine A 
(1) 
NHo 
Z-Huperzine A 
(3) 
Figure 2. The structures of the alkaloids, huperzine B, 
huperzine A, and Z-huperzine A. 
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Scheme I 
path b 
path a 
N^^^0CH3 
^"O OEt 
path a 
C02Me 
path b 
COgMe 
NHn 
(1) 
path a 1) i. MeI/Ag2C03/THF; ii. LAH/ether; iii. PhLi/HCHO/ether; iv. SOCI2/ 
CHCI3; V. NaCN/DMSO; vi. MeOH/HCl; vii. NaH/THF. 2) i. meth-
acrolein, MeOH; ii. MsCl, NaOAc; iii. ethyhdenetriphenylphosphorane. 
3) i. KOH/MeOH, ii. (PhO)2PON3; iii. MeaSiCl/Nal/CHsCN; iv. KOH. 
path b 1) i. pyrrolidine; ii. acrylamide; iii. H2O, iv. KH, BnCl; v. 
LDA/PhSeCl/NaI04; vi. H2, Pd(0H)2/C, AcOH; vii. Mel, Ag2C03; viii. 
H3O+; ix. KH, (MeO)2CO. 2) i. methacrolein, TMG; ii. MsCl/NaOAc; iii. 
ethyhdenetriphenylphosphorane. 3) i. PhSH/AIBN; ii. NaOH/MeOH; iii. 
SOCI2; iv. NaNa/MeOH; v. TMSI. 
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Kozikowski has improved his route by utihzing a palladium-catalyzed 
bicycloannulation.® Our approach differs from these routes in that the amine 
is introduced via a bridgehead enone7 
Scheme II outlines the retros3aithetic analysis of our approach. The 
bicyclic framework is formed by a Michael-aldol process from the keto 
sulfoxide and methacrolein. A Wittig reaction is used to introduce the 
exocyclic ethylidene moiety. The key step involves elimination of the 
bridgehead sulfoxide to give the reactive 'bridgehead enone intermediate 
which reacts with a molecule of ammonia to yield the bridgehead amine.® 
Scheme II 
^3 
-NHc 
H T 
11 
-NH. 
CH; 
T 
10 
-SOPh 
SOPh 
Our approach differs from the previous syntheses. The sjnithesis starts 
from the readily available monoketal of 1,4-cyclohexanedione (4). The 
21 
intermediate (3-keto ester that is common to both the Kozikowski and Qian 
and Ji syntheses is not used. This intermediate is difficult to prepare and at 
best offers a yield of 39%. Also, our route introduces the bridgehead amine by 
a unique bridgehead enone reaction. Both of the previous routes used a 
Curtius rearrangement to introduce the bridgehead amine. This reaction, 
the conjugate addition to a bridgehead enone, can accommodate a number of 
different nucleophiles which would allow for a variety of new analogs. 
Before our synthetic pathway is discussed, it is worthwhile to review 
bridgehead enones. House and coworkers contributed to the study of 
bridgehead enone stability.® Magnus was the first to utilize a bridgehead 
enone generated by a sulfoxide elimination in the s3mthesis of Kopsane 
alkaloids.® Kraus prepared an important intermediate in the synthesis of 
lycopodine by a bridgehead enone prepared from the bridgehead bromide and 
3-amino-l-propanol and DBU.l^ Bridgehead enones, as demonstrated in the 
following s3aithesis, have proven to be useful tools in the s3aithesis of natural 
products. 
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DISCUSSION AND RESULTS 
Our approach starts with the commercially available mono ketal of 
1,4-cyclohexanedione (4). Generation of the enolate of 4 with lithium 
tetramethylpiperidide (LiTMP) in THF at -78 °C and trapping of the enolate 
with diphenyldisulfide resulted in the formation of a keto sulfide which was 
oxidized to the sulfoxide 5 with MCPBA at 0 °C. Another route to the 
ketosulfoxide, 5, involved generation of the lithium enolate with lithium 
diisopropylamide (LDA) and trapping of the enolate with chlorotri-
methylsilane (TMSCl). This provided the enol silyl ether in 88% yield. 
Reaction of the enol silyl ether with p-toluenesulfinyl chloride and tin 
tetrachloride gave the sulfoxide in 45-55% yield. ^  The first method was 
preferred because it proceeded in a better yield (55% overall yield). 
The bicyclic compound 6 was prepared in 90% yield by the addition of 
methacrolein to a solution of 5 and l,8-diazabicyclo[5.4.0]undec-7-ene (DBU) 
in acetonitrile. The cis stereochemistry shown was determined by a 2D 
NOESY experiment on 10. Next, the hydroxyl group was protected in order to 
prevent a retroaldol cleavage during the Wittig reaction. The trimethylsilyl 
ether 7 was reacted with ethylidenetriphenylphosphorane in THF to afford 
Z-olefin 8. Unfortunately, the reaction provided a yield which was no greater 
than 50%. In an attempt to improve the yield, ketone 7 was treated with ethyl 
magnesium chloride to afford the tertiary alcohol 9 in quantitative yield. 
However, all attempts to eliminate the alcohol led to recovered starting 
material or decomposition. 
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Scheme III 
1) LiTMP, PhSSPh f ^SOPh i)CH2=C(CH3)CHO, ^ 
2) MCPBA DBU 
2) TMSCl 
1) Ph3P=CHCH3 
CHa 
EtMgCl 
CHa 
SOPh 
0^0 \__y 
•SOPh 
1) H3O + 
Y 
o 
10 
-K- 10 
<vX^ 
50Ph 
§ 
6: R = H 
7: R = TMS 
fHa 
•SOPh 
In order to investigate the proposed bridgehead enone reaction, ketal 8 
was hydrolyzed to give 10. However, the sulfoxide did not eliminate even at 
temperatures as high as 285 °C. This result conflicted with our previous 
findings (Scheme IV). 12 
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Scheme IV 
He 
O 
CH. 
Q 
-SOPh 
EtgN 
130 °C KJ 
Because 10 was reluctant to eliminate under thermal conditions, we 
decided to explore other avenues to the bridgehead enone. We discovered that 
the sulfoxide 10 when heated in a sealed tube in aqueous ammonium 
hydroxide at 130 °C for three hours was converted into amine 11 in 75% yield 
(Scheme V). 
Scheme V 
10 
NH4OH 
130 °C 
CH; 
h c k A  
I 
Y 
o 
II 
-NH. 
The synthesis of the amino ketone 11 from the sulfoxide 10 proved that 
the amine could be introduced by a bridgehead enone. Completion of the 
synthesis involves the dehydration of the secondary alcohol and 
isomerization of the exocyclic alkene. Then, regioselective appendage of the 
P3Tidone ring would yield huperzine A. Since both the elimination and 
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isomerization have precedent from the Kozikowski synthesis, this offers 
direct approach to huperzine A and improved analogs (Figure 3). 
alkene 
double-bond 
isomerization 
J J pyridone 
Figure 3. Double-bond isomerization, dehydration to the 
endocyclic olefin, and pyridone appendage would 
give huperzine A 
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CONCLUSION 
Huperzine A and its analogs continue to be attractive synthetic targets. 
An efficient and simplified synthesis would make available this useful 
natural product for experimentation as a potential treatment for cholinergic 
disorders. Moreover, the s3aithesis of analogs would permit the 
determination of structural modifications necessary for enhanced biological 
activity. 
This study has provided an efficient and creative route to the bicyclic 
core of huperzine A. It has simplified the synthesis significantly since it 
starts from readily available materials and consists of few steps. 
Furthermore, utilization of the bridgehead enone yields a flexible route to 
improved analogs. In the future, it may lead to a very direct route that would 
allow for concomitant addition of the amine and regioselective appendage of 
the pyridone ring in one step (Scheme VI). 
Scheme VI 
/ 
•SOPh 
H-N-CH=CHC-NH2 
O 
A 
O 
27 
EXPERIMENTAL 
All materials were obtained from commercial suppliers and used without 
purification, unless specified otherwise. The solvents, diethyl ether (Et20) 
and tetrahydrofuran (THF) were distilled from sodium benzophenone ketyl. 
Benzene was distilled after drying over lithium aluminum hydride. Both 
dichloromethane and acetonitrile were distilled over calcium hydride. The 
reactions were performed under nitrogen atmosphere. During the workups, 
all extracts were dried over sodium sulfate. Apparati for the experiments 
were flame-dried under a stream of nitrogen. EM Science Kieselgel F254 
prepared plates with thicknesses of 0.25 mm were used during thin-layer 
chromatography. The eluents used were appropriate mixtures of hexanes (H) 
and ethyl acetate (EA). A Perkin Elmer 1320 spectrophotometer (300 MHz) 
was used to obtain infrared spectra. The data were reported in cm-l. A 
Nicolet Magnetics Corporation NMC-1280 spectrometer was used to obtain 
proton nuclear magnetic resonance spectra (300 MHz). All chemical shifts 
were reported in ppm relative to tetramethylsilane. The splitting patterns 
were reported as s for singlet, d for doublet, t for triplet, q for quartet, and dd 
for double of doublets. The AB quartet was designated as ABq, and the 
multiplet as m. The abbreviation br was used to indicate a broadened 
pattern. The Nicolet NMC-1280 spectrometer was used to obtain Carbon-13 
NMR spectra (75.46 MHz). The values were reported in 6 relative to CDCI3 
(77.0 ppm). The mass spectrometer used was a Finnegan 4023 mass 
spectrometer. The spectra obtained were high resolution mass spectra. 
Galbraith laboratories performed all elemental analyses. The compounds 
were judged to be a 90% pure by ^H NMR spectral determinations. 
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7-(Phenylsulfinyl)-l,4-dioxaspiro[4.5]decan-8-one (5): To a solution 
of 2,2,6,6-tetramethylpiperidine (6.36 g, 45 mmol) in 25 mL of THF at -40 °C 
was added n-BuLi (23.3 mL of a 1.93 M solution in hexanes). The solution was 
warmed to room temperature over 30 minutes. The solution was cooled to 
-40 °C and a solution of 1,4-cyclohexanedione monoethylene ketal (4) in 7 mL 
of THF and 30 mL of HMPA was added over 15 minutes. The solution was 
slowly warmed to room temperature over 2 hours. The solution was cooled to 
-15 °C and a solution of diphenyldisulfide in 20 mL of THF was added over a 
period of 10 minutes. The solution was stirred at room temperature for 8 
hours. The reaction was quenched by adding 1 N HCl until the pH was below 
7. The mixture was extracted three times with Et20. The combined Et20 
solutions were washed with water and saturated aqueous NaCl solution, 
dried, and concentrated. The residue was purified by sgc. Elution with 
hexanes removed unreacted diphenyldisulfide. Elution with 10:1 H:EA, then 
with 3:1 H:EA, provided 4.32 g (82%) of an amorphous solid: Rp 0.67 (3:1 
H:EA); iH NMR (300 MHz, CDCI3) 8 2.0-2.85 (m, 7H), 3.9-4.15 (m, 4H), 7.2-7.45 
(m, 5H). 
To a solution of the keto sulfide (3.67 g, 13.9 mmol) in 65 mL of CH2CI2 at 
0 °C was added MCPBA (3.11 g, 15.3 mmol) in portions over a 5 minute period. 
The mixture was stirred at 0 °C for 30 minutes. Saturated NaHCOa solution 
was added and the layers were separated. The aqueous layer was extracted 
three times with CH2CI2 and the combined organic layers were washed twice 
with saturated NaHCOa solution and once with saturated NaCl solution. The 
solution was dried and concentrated. The residue was purified by sgc with 
100 mL of 1:1 H:EA, then 200 mL 1:3 H:EA and finally with EtOAc. Removal 
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of solvent gave 2.67 g (69%) of a white powder: Rp 0.43 (1:3 H:EA); NMR 
(300 MHz, CDCI3) 8 1.8-1.9 (m, IH), 2.0-2.1 (m, 2H), 2.45-2.75 (m, 3H), 3.60 (dd, 
J = 7.7, 13.3 Hz, IH), 3.85-4.05 (m, 4H), 7.47-7.65 (m, 5H). 
6-Hydroxy-7-methyl-l-(phenylsulfinyl)spiro[bicyclo[3.3.1]-
nonane-3,2'-[l,3]dioxolane]-9-one (6): To a solution of 5 (1.48 g, 5.28 
mmol) and DBU (0.88 g, 5.8 mmol) in 50 mL of CH3CN (freshly distilled from 
CaH2) was added dropwise a solution of methacrolein (1.40 g, 20 mmol) in 10 
mL of CH3CN. The solution was stirred for 30 minutes and was concentrated. 
The residue was purified by sgc with 1:1 H:EA, 1:4 H:EA and finally with EA 
to give 1.68 g (91%) of a white solid: Rf 0.30 (1:3 H:EA); ^H NMR (300 MHz, 
CDCI3) 5 diastereomers, 1.18 (d, J = 7.7 Hz), 1.20 (d, J = 7 Hz, total of IH), 
1.7-2.5 (m, 4H), 2.87-2.95 (m, IH), 3.25-3.35 (m, 2H), 3.55-4.0 (m, 5H), 7.46-7.66 
(m, 3H), 7.8-7.86 (m, 2H); IR (CDCI3) 3370, 3046, 2960, 2880, 1716, 1440, 1160, 
1080, 1030 cm-1; MS (NH3 CI) miz 351, 368. 
9-Ethylidene-7-methyl-l-(phenylsulfinyl)-6-(triinethylsilyloxy)-
spiro[bicyclo[3.3.1]]ionane-3,2'-[l,3]dioxolane] (8): To a solution of 6 (70 
mg, 0.2 mmol) in 1 mL of pjTidine was added TMSCl (44 mg, 0.4 mmol). The 
solution was stirred for 30 minutes and then poured into 20 mL of Et20. The 
mixture was filtered and washed with 20 mL of Et20. Solvent was removed 
and the residue was dissolved in benzene. The mixture was decanted and 
solvent and pyridine were removed to give 78.3 mg (93%) of 7: Rp 0.35 (1:1 
H:EA); IH NMR (300 MHz, CDCI3) 6 0.08 (s, 9H), 1.0 (d, 7.3H), 1.80-2.95 (m, 
2H), 2.0-2.35 (m, 6H), 2.45-2.6 (m, 2H), 3.15-3.25 (m, IH), 3.45-3.60 (m, 3H), 
3.8-3.9 (m, IH), 7.40-7.45 (m, 3H), 7.8-7.85 (m, 2H); IR (CDCI3) 3025, 2945, 2880, 
1720, cm"l. To ethyltriphenylphosphonium bromide (4.7 g, 12.5 mmol) in a 50 
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mL flask was added 30 mL of benzene. The benzene was distilled off to remove 
any water present. The flask was allowed to cool and 10 mL of THF was 
added. To the suspension of the phosphonium salt in THF was added n-BuLi 
(5.2 mL of 1.93 M). The solution was stirred for 10 minutes then was cooled to 
0 °C. A solution of 7 (2.11 g, 5 mmol) in 10 mL of THF was added dropwise and 
the solution was stirred at room temperature for 16 hours. The solution was 
poured into 400 mL of 3:1 pentane:Et20. A small amount of acetone was 
added to quench any unreacted ylide. The mixture was filtered through 
Celite and the solvent was removed. The residue was purified by sgc with 3:1 
H:EA to give 1.15 g (53%) of a white solid: Rf 0.47 (1:1 H:EA); ^H NMR (300 
MHz, CDCI3) 8 0.12 is, 9H), 0.95 (d, J = 7.0 Hz, 3H), 1.7-2.5 (m, 8H), 1.78 (d, 
J = 7.3 Hz, 3H), 2.80-2.87 (m, IH), 3.5-3.85 (m, 4H), 6.12 (q, J = 7.3 Hz, IH), 
7.5-7.9 (m, 5H); IE (CDCI3) 3055, 2950, 1720, 1580, 1250, 1080 cm-1. 
9-Ethyl-6,9-dihydroxy-7-methyl- l-(phenylsulfinyl)-
spiro[bicyclo[3.3.1]nonane-3,2'-dioxolane] (9): To a solution of 6 (0.42 g, 
1.0 mmol) and TMSCl (0.02 g, 0.2 mmol) in 5 mL of THF at -78 °C was added 
ethylmagnesium bromide (0.83 mL of a 3 M solution in Et20) dropwise. After 
15 minutes, acetic acid (0.14 mL, 2.5 mmol) was added and the solution was 
poured into brine. The mixture was extracted with Et20 and the organic 
phase was dried and concentrated to give 0.45 g (100%) of diol 9: ^H NMR 
(300 MHz, CDCI3) 8 0.96 (d, J = 7 Hz, 3H), 1.16 (t, J = 8 Hz, 3H), 1.9-2.5 (m, 6H), 
2.67 (d, J = 19.7 Hz, 2H), 2,86 (d, J = 21 Hz, 2H), 3.97 (dd, J = 5, 12 Hz, IH), 4.73 
(s, IH), 7.47-7.55 (m, 5H). 
9-Ethylidene-6-hydroxy-7-inethyl-l-(phenylsulfinyl)-
bicyclo[3.3.1]nonan-3-one (10): To a solution of 8 (0.43 g, 1 mmol) in 10 mL 
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of THF was added 1 mL of H2O and 10 drops of H2SO4. The solution was 
stirred for 1 hour and saturated NaHCOs solution was added. The aqueous 
layer was saturated with NaCl and the mixture was extracted twice with 
Et20. The combined extracts were dried and concentrated to give 0.22 g 
(69%) of a white solid: iR NMR (300 MHz, CDCI3) 6 1.01 (d, J = 6.7 Hz, 3H), 
1.24-1.51 (m, 2H), 1.83-2.05 (m, 2H), 1.87 (d, J = 7.5 Hz, 3H), 2.24-2.45 (m, 2H), 
2.96 (d, J = 19 Hz, IH), 3.33-3.45 (m, 2H), 6.36 (q, J = 7.5 Hz, IH), 7.5-7.62 (m, 
5H); MS (NH3 CI) miz 363, 380. 
l-Amino-9-ethylidene-6-hydroxy-7-methylbicyclo[3.3.1]nonan-
3-one (11): A suspension of 10 (75 mg, 0.24 mmol) in 2 mL of saturated 
aqueous NH4OH solution was heated to 120 °C in a teflon-capped culture tube 
for 3 hours. The mixture was cooled, diluted with saturated NaCl solution 
and extracted three times with CH2CI2. The combined extracts were dried 
and concentrated. The residue was placed on a short column of silica gel and 
eluted with EtOAc to remove side products. Eluting with MeOH provided 
36.3 mg (73%) of a brown solid: iH NMR (300 MHz, CDCI3) 8 0.97 (d, J = 6.2 
Hz, 3H), 1.14 (td, J = 1.7, 14 Hz, IH), 1.5-1.8 (m, 2H), 1.74 (d, J = 6.8 Hz, 3H), 
2.04 (dd, J = 8, 19 Hz, IH), 2.15-2.35 (m, 2H), 2.91 (br d, J = 19 Hz, IH), 3.23 
3.35 (m, 2H), 5.73 (q, J = 6.8 Hz, IH); IE (CDCI3) 3615, 3375, 3060, 2960, 1700, 
1630, 1050 cm-1; MS (NH3 CI) mIz 210, 227. 
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PAPER II: A DIRECT ROUTE TO FUNCTIONALIZED PYRIDONES 
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BACKGROUND 
It has been well established that huperzine A is a promising 
acetylcholinesterase (AChE) inhibitor.1 The current working hypothesis is 
that AChE inhibitors will improve cognitive function. Today, most industrial 
scientists believe that AChE inhibitors will have a significant impact on 
Alzheimer's disease. Recently, tacrine (an AChE inhibitor) has been 
approved by the FDA as a therapeutic drug for the treatment of Alzheimer's 
disease. 
Huperzine A is a reversible inhibitor of acetylcholinesterase. The 
discovery of the remarkable anti-acetylcholinesterase activity of huperzine A 
has prompted considerable attention from both pharmacologists and 
synthetic chemists.2 
As part of a study designed to identify analogs of huperzine A with 
improved AChE inhibitory activity,3 we required a direct synthesis of 
6-substituted pyridones. A direct route to these compounds would involve the 
conjugate addition of a side-chain metallated pyridine with an 
a,p-unsaturated ketone (Scheme I). 
Scheme I 
M 
M = metal 
It has been well documented that 2-methylpyridine anions undergo 
aldol^ and alkylation^ reactions. Danishefsky and Cain prepared 
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picolylbutyraldehyde by reaction of 2,6-lutidine with phenyllithium and 
treatment of the resulting anion with 3-chloropropionaldehyde diethylacetal 
(Scheme II).® 
Scheme II 
1) THF, 0 °C- •II 
X)— 2) H,,0* 
Lipshutz prepared the higher order cuprate of 2-picoline by treatment 
with two equivalents of /i-BuLi and one equivalent of copper(I) cyanideJ He 
used this reagent in an alkylation reaction with a primary bromide to give 
the coupled product (Scheme III). 
Scheme III 
<#<^Cu(CN)Li2 
THF ^ 
-50 °C 
93% 
To the best of our knowledge, the use of these anions as donors in 
conjugate addition reactions has no precedent.^ Enones 2 and 3 and 
pyridones 4a-e were used to explore this pathway (Scheme IV). 
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Scheme IV 
Y X 2: R=H 
3: R=CMe=CH2 
X 
4a: X=Y=H, Z=C1 
4b: X=H, Y=C02Me, Z=C1 
4c: X=Y=SMe, Z=C1 
4d: X=Y=SMe, Z=OMe 
4e: X=Y=SMe, Z=0CH2Ph 
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DISCUSSION AND RESULTS 
Pjnridine 4a was deprotonated using LDA in THF at 0 °C. The resulting 
anion was reacted at -78 °C with Z-carvone to yield alcohol 5 in 84% yield. We 
did not observe any product resulting from 1,4-addition. Although many 
options exist for securing 1,4-addition via organocuprates or higher order 
cuprates, the addition of CuCN, or CuCN-HMPA did not change the 
regioselectivity (Scheme V). 
Scheme V 
4a 
1) n-BuLi, 
5 
84% 
4a 
1) re-BuLi, CuCN, THF 
O 
5 
69% 
4a 
1) /i-BuLi, CuCN, THF 
O 5 100% 
f , THF, HMPA 
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We next elected to increase the acidity of the anion. Therefore, ester 4b 
was prepared by reaction of the anion of 4a with carbon dioxide followed by 
DCC-mediated esterification (34% overall yield). Although the lithium anion 
was not reactive, the potassium anion formed with potassium tert-butoxide 
provided the unexpected bicyclic adduct 6 (Scheme VI). 
Scheme VI 
4a 
1) CO2, nBuLi 
2) MeOH, DCC, DMAP 
KOtBu 
COgMe 
COgMe 
4b 
34% 
A likely mechanism would involve Michael addition followed by internal 
nucleophilic attack on the ester by the enolate (Scheme VII). 
The reaction of the lithium anion of 4a with dimethyl disulfide and 
subsequent addition of a second equivalent of n-BuLi and dimethyl disulfide 
generated p3nridine 4c in 81% overall yield. The dithiane, 4c, was then 
deprotonated with n-butyl lithium and reacted with Z-carvone in the presence 
of HMPA to yield the ketone, 7, in a 52% overall yield as a single diastereomer. 
The yield of 7 was improved to 98% by the addition of Cul. Unfortunately, we 
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Scheme VII 
KO'Bu 
COoMe 
COoMe 
C02Me 
Et' 
were unable to transform 7 into a pyridone by nucleophilic displacement of 
the chloride. Perhaps, competing aldol condensations occurred (Scheme VIII). 
Our next objective was to introduce an oxygen substituent prior to the 
conjugate addition step. The reaction of 4a with sodium methoxide in 
methanol^ followed by introduction of the me thy Ithio groups with n-BuLi and 
dimethyl disulfide afforded pyridine 4d in 30% yield. The yield was increased 
to 58% by reversing the order of the steps. Thus, 4c was heated in a sealed 
tube at 120 °C in a sodium methoxide solution. The resulting methyl ether 
was deprotonated with /i-butyllithium and the corresponding anion was 
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reacted with /-carvone in the presence of HMPA to afford the ketone 8 in 61% 
yield. Unfortunately, attempts to liberate the pyridone by treating the 
Scheme VTIT 
1) n-BuLi, MeSSMe 
2) n-BuLi, MeSSMe 
4a SMe 
4c 
Me 
SMe 
4c 
MeS 
CI 
SMe 
4c 
1) n-BuLi, THF, HMPA X. 
CI 
1) n-BuLi, Cul, THF 
^Y'^"'X^N^ci I 
7 (52%) 
7 (98%) 
„ MeO - Na^ 
7 7/ 8 
PhCHaO -
7 —y/ 9 
methyl ether with Lewis acids failed. 10 Consequently, a more labile 
protecting group was investigated (Scheme IX). 
41 
Pyridine 4e was prepared from 4c by displacement of the chloride using 
sodium benzyloxide in benzyl alcohol. Generation of the anion of 4e by 
treatment with /i-BuLi at -78 °C in THF, followed by addition of HMPA and 
Scheme IX 
1) NaOMe, MeOH 
N^OM 
4d 58% 
Me 
1) n-BuLi, Cul 
OMe 
SMe 
4d 58% 
f 
8 61% 
OMe 
8 
Z-carvone furnished the ketone 9 in 9% overall yield. The yield of 9 was 
improved to 99% by the addition of Cul (Scheme X). 
The transformation of 9 into the pyridone 10 was the next objective. The 
reaction of 9 with TMSI failed to give the desired pyridone. Attempted 
deprotection using catalytic hydrogenation (Pd/C, H2) gave starting material 
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only. Fortunately, treatment of 9 with Raney nickel^^ provided p3a-idone 10 
in 85% yield (Scheme XI). 
Scheme X 
Me 
SMe 
4c 
PhCHoO ^ K" 
C1 O "Ph 
SMe 
4e 90% 
1) n-BuLi, THF 
HMPA 
9 9% 
^Ph 
4e 
2) 
Table I summarizes our results. In order to test the reliability of the 
conjugate addition, the anions of 4a and 4c were reacted with 
2-cyclohexene-l-one. As expected, the anion formed by deprotonation of 
6-chloro-2-picoline with lithium diisopropylamide upon treatment with the 
ketone gave the corresponding ally lie alcohol (64% yield). Finally, 
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deprotonation of 4c with n-BuLi and addition of Cul followed by reaction with 
2-cyclohexene-l-one gave the 1,4-addition product in quantitative yield. 
Scheme XI 
TMSI 
H2, cat. Pd-C 
RaNi 
85% 
9  
Table I. The reaction of p3a-idyl anions with carvone 
HO 
+ 
R 
Y X 
R 
R R' X Y Z Base Product % Yield Compound 
1 C(Me)CH2 Me H H 01 LDA 1,2 84 5 
2 C(Me)CH2 Me H H 01 n-BuLi, OuON 1,2 69 5 
3 C(Me)CH2 Me H H 01 n-BuLi, OuON 1,2 100 5 
HMPA 
A 
4 C(Me)CH2 Me H C02Me 01 t-BuOK 11 6 
0^ O 
5 C(Me)CH2 Me SMe SMe 01 n-BuLi, HMPA 1,4 52 7 
6 C(Me)CH2 Me SMe SMe 01 n-BuLi, Oul 1,4 98 7 
Table I. Continued 
R R' X Y Z Base Product % Yield Compound 
7 C(Me)CH2 Me SMe SMe OMe n-BuLi, HMPA 1,4 61 8 
8 C(Me)CH2 Me SMe SMe 0CH2Ph ra-BuLi 1,4 9 9 
9 C(Me)CH2 Me SMe SMe 0CH2Ph n-BuLi, Cul 1,4 99 9 
10 H H H H CI LDA 1,2 64 
11 H H SMe SMe CI n-BuLi/CuI 1,4 100 
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CONCLUSION 
In conclusion, it was demonstrated that the conjugate addition of 
metallated alkylpyridines to enones occurs with high regioselectivities and 
yields. Two methods were used to secure this transformation. 
First, acidity of the Michael donor was increased by adding anion-
stabilizing groups. The dithiane, 4c, was found to be the most successful and 
has a pKa of approximately 30. This acyl anion equivalent was readily 
reduced with raney nickel. Although there are numerous examples of 
conjugate additions of alkyl dithianes, we are unaware of any derived from 
2-picoline. 
Second, the addition of one-half equivalent of Cul to the lithiated 
heteroaromatic species resulted in all cases in improved yields (Scheme XII). 
Scheme XII 
C 
SMe + n-BuLi 
THF 
C 
SMe^^ 
SMe 
4c SMe 
CI ^SMe ?^SMe 
+ Cul 
C 
SMe 
-SMe 
Cu 
+ Lil 
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Two reviews have been written covering substitution and conjugate 
addition reactions in organocopper chemistry well over a decade ago.l^ These 
reagents have proven to be of tremendous value to the synthetic organic 
chemist. In fact, it is indeed rare to find a journal that does not contain a 
copper-mediated carbon-carbon bond transformation. This study 
demonstrated the great utility of these reagents and to the best of our 
knowledge illustrated one of the first methods utilizing the "heteroaromatic 
Oilman reagent" in a 1,4-conjugate addition. 
Lipshutz and Sengupta wrote, "The true measure of the value of an 
organotransition metal reagent lies in the extent to which it is successfully 
employed, allowing a transformation to be realized which might otherwise 
require multiple steps to achieve."!'^ This strategy has clearly done just that. 
The direct synthesis of the pyridone 10 showed that our conjugate 
addition/deprotection strategy is a reliable one. The two step pathway 
proceeds in good yields with complete regioselectivity. 
Finally, since pyridones are common structural subunits in huperzine A, 
this route should have great utility. It offers simplicity as well as flexibility 
toward the sjnithesis of huperzine A and improved analogs. 
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EXPERIMENTAL 
All materials were obtained from commercial suppliers and used without 
purification, unless specified otherwise. The solvents, diethyl ether (Et20) 
and tetrahydrofuran (THF) were distilled from sodium benzophenone ketyl. 
Benzene was distilled over lithium aluminum hydride. Both dichloromethane 
and acetonitrile were distilled over calcium hydride. Most of the reactions 
were performed under nitrogen atmosphere; however, argon gas was used in 
most of the conjugate addition reactions. The Cul was purified prior to use.^® 
The activated raney nickel was prepared from W2 raney nickel, All 
apparati for the experiments were flame-dried under a stream of nitrogen. 
EM Science Kieselgel F254 prepared plates with thicknesses of 0.25 mm were 
used during thin-layer chromatography. The eluents used were appropriate 
mixtures of hexanes (H) and ethyl acetate (EA). A DigiLab FTS-7 (FT-IR 
spectrometer) and an IBM/Bruker IR-98 (FT-IR spectrometer) were used to 
obtain infrared spectra. A Nicolet Magnetics Corporation NMC-1280 
spectrometer was used to obtain proton nuclear magnetic resonance spectra 
(300 MHz). All chemical shifts were reported in ppm relative to 
tetramethylsilane. The splitting patterns are reported by the following 
designations: s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of 
doublets; ABq, AB quartet; and m, multiplet. The Nicolet NMC-1280 
spectrometer was used to obtain Carbon-13 NMR spectra (75.46 MHz). The 
values were reported in 6 ppm relative to CDCI3 (77.0 ppm). The mass 
spectrometer used was a Finnegan 4023 mass spectrometer. The compounds 
were judged to be a 90% pure by ^H NMR spectral determinations. 
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1-(6-Chloro-2-methylpyridyl)-2-methyl-5-isopropenylcyclohex-2-
enol (5): To a solution of LDA, freshly prepared from n-BuLi (2.17 M in 
hexane; 0.74 mL, 1.6 mmol) and ATjAT-diisopropylamine (0.16 g, 1.6 mmol) in 
dry THF (32 mL) was added 6-chloro-2-picoline (0.20 g, 1.6 mmol) at 0 ®C. 
After stirring for 30 minutes, the solution was cooled to -78 °C and 1-carvone 
(0.24 g, 1.6 mmol) in THF (2 mL) was added dropwise. The solution was 
stirred for two hours and then poured into ice water and extracted with 
diethyl ether (3 X 20 mL). The combined extracts were washed with brine 
and dried over MgS04. The residue was purified by silica gel 
chromatography (hexane; AcOEt, 8:1) to give alcohol, 5, in 84% yield. 
IR (film) 3415, 3081, 2921, 1645, 1550, 1408, 1183 cm-1; IH NMR (300 
MHz, CDCI3) 8 7.59 (t, J = 7.8 Hz, IH), 7.21 (d, J = 7.8 Hz, IH), 7.08 (d, J = 7.5 
Hz, IH), 5.49-5.47 (s, IH), 4.66 (s, 2 H), 3.24 (d, J = 14.4 Hz, IH), 2.94 (d, J = 
14.4 Hz, IH), 2.44-2.27 (m, 2H), 2.19-1.89 (m, 4H), 1.76 (s, 3H), 1.65 (s, 3H); MS 
(CI, NH3) m/e 277; HRMS (EI) calcd for C16H20CINO (M+) 277.12276, found 
(M+) 277.12334; CMR (CDCI3) 817.3, 20.3, 30.7, 39.6, 40.3, 44.1, 74.2, 108.9, 
122.0,123.1, 123.6, 138.2, 139.1, 148.5, 150.3, 160.0; TLC (4:1, H:EA) Rf = 0.39. 
2-Methyl-8-isopropylene-6-(6-chloro-2-pyridyl)-bicyclo[2.2.2]-
octan-3,5-dione (6): To a solution of potassium tert-butoxide (0.65 mmol) in 
THF was added 2-methylethanoate-6-chloropyridine (0.59 mmol) at 0°. The 
solution was stirred for 30 minutes. L-carvone (0.65 mmol) was added and the 
mixture was stirred overnight at room temperature. Then, the temperature 
was raised and the mixture was refluxed for 12 hours. The crude mixture 
was poured into ice water and extracted with ether. The combined extracts 
were dried over MgS04. The residue was purified by silica gel 
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chromatography (hexane;AcOEt, 12:1) to give the [2.2.2]bicyclo adduct in 11% 
yield. 
IR (film) 3055, 2988, 1701, 1421 cm-1; IR NMR (300 MHz, CDCI3) 6 8.01 
(d, J = 7.5 Hz, IH), 7.83 (t, J = 7.8 Hz, IH), 7.53 (d, J = 7.8 Hz, IH), 5.00 (s, IH), 
4.82 (s, IH), 4.16-4.08 (m, IH), 2.90-2.40 (m, 4H), 1.91 (s, 3H), 1.88-1.65 (m, 2H), 
1.01 (d, J = 6.6 Hz, 3H), Rf = 0.53 (3:1, H:EA). 
2-Methyl-5-isopropenyl-3-[(6-chloro-2-pyridyl)bis-methylthio-
methyl]cyclohexanone (7): To a stirred solution of 4c (143 mg, 0.65 mmol) 
in THF (5 mL) was added n-BuLi (0.30 mL, 0.65 mmol) at -78 °C under an Ar 
atm. The mixture was stirred for one hour. Cuprous iodide (63 mg, 0.33 
mmol) was then added and the mixture stirred for an additional hour at 
-78 °C. Then 1-carvone (50 mg, 0.33 mmol) in 0.1 mL of THF was added slowly 
at -78 °C and the mixture was stirred at -78 °C for three hours. The reaction 
mixture was quenched by the addition of H2O and allowed to reach room 
temperature. The precipitate was filtered off and the crude mixture was 
extracted with Et20. The extract was washed with brine, dried over MgS04, 
and concentrated to give a residue, which was purified by silica gel 
chromatography (hexane:AcOEt, 30:1) to give 7 (98% yield). 
IR (film) 2915, 2872, 1708, 1558, 1427 cm-1; iR NMR (300 MHz, CDCI3) 6 
7.82 (d, J = 7.5 Hz, IH), 7.67 (t, J = 7.5 Hz, IH), 7.22 (d, J = 7.8 Hz, IH), 4.81 
(s, IH), 4.77 (s, IH), 2.94-2.81 (m, IH), 2.46-1.83 (m, 6H), 2.03 (s, 3H), 1.93 (s, 
3H), 1.78 (s, 3H), 0.61 (d, J = 6.6 Hz, 3H); MS (CI, NH3) m/e 322, 370, 387; CMR 
(CDCI3) 6 12.8, 13.6, 20.6, 28.1, 42.1, 44.5, 47.6, 48.2, 71.3, 110.1, 122.1, 122.8, 
138.5, 147.0, 149.7, 160.4, 213.2; TLC (4:1, H:EA) Rf = 0.57. 
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2-Methyl-5-isopropenyl-3[(6-methoxy-2-pyridyl)bis-(methyl-
thio)methyl]cyclohexanone (8): To a stirred solution of 4d (67 mg, 0.31 
mmol) in 3 mL of THF was added n-BuLi (0.16 mL, 0.34 mmol) at -78 °C. The 
solution was stirred for one hour at -78 °C and then the temperature was 
raised to 0 °C and HMPA (0.06 mL, 0.34 mmol) was added. The temperature 
was lowered to -78 °C and 1-carvone (51 mg, 0.34 mmol) was added dropwise. 
The reaction mixture was stirred at -78 °C for three hours. The reaction 
mixture was quenched by the addition of water and allowed to reach room 
temperature. The aqueous solution was extracted with Et20, washed 
successively with H2O and brine, and dried (MgS04). Silica gel 
chromatography (70:1, H:EA) of the residue afforded 8 in 61% yield. 
IR (film) 2924, 1711, 1587, 1466, 1263, 1020 cm-1; IR NMR (300 MHz, 
CDCI3) 8 7.58 (t, J = 7.5 Hz, IH), 7.45 (d, J = 7.5 Hz, IH), 6.61 (d, J = 8.1 Hz, 
IH), 4.83-4.71 (m, 2H), 3.93 (s, 3H), 2.99-2.88 (m, IH), 2.50-1.22 (m, 6H), 2.02 (s, 
3H), 1.92 (s, 3H), 1.78 (s, 3H), 0.91 (d, J = 7.2 Hz, 3H); MS (CI, NH3) m/e 208, 
320, 366; HEMS (EI) calcd for C19H27NO2S2 (M+) 365.1483, found (M+) 
365.1484; CMR (CDCI3) 8 18.4, 20.5, 28.4, 42.1, 44.6, 47.6, 48.2, 53.5, 72.5, 
109.3, 109.9, 116.4, 123.0, 127.1, 138.5, 147.1, 156.4, 162.8, 213.6; TLC (7:1, 
H:EA)Rf=0.71. 
2-Methyl-5-isopropenyl-3[(6-ben2yloxy-2-pyridyl)bis-methylthio-
methyl]cyclohexanone (9): This compound was prepared following the 
procedure for the preparation of 7. The product was purified by silica gel 
chromatography (30:1, H:EA) to give 9a and 9b (4:1-99:1, 9a:9b). 
9a (trans isomer): IR (film) 2915, 1708, 1574, 1441 cm^l; ^H NMR (300 
MHz, CDCI3) 6 7.59 (t, J = 7.8 Hz, IH), 7.50-7.23 (m, 6H), 6.67 (d, J = 8.4 Hz, 
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IH), 5.39 (AB quartet, J = 12.3 Hz, 2H), 4.79 (s, IH), 4.76 (s, IH), 2.93-2.91 (m, 
IH), 2.46-1.71 (m, 6H), 2.01 (s, 3H), 1.89 (s, 3H), 1.76 (s, 3H), 0.73 (d, J = 7.2 Hz, 
3H); MS (CI, NH3) m/e 382, 396, 442; CMR (CDCI3) 6 12.8, 13.5, 20.5, 28.1, 
40.0, 42.1, 44.8, 47.6, 48.3, 67.6, 72.8, 109.5, 110.0, 118.8, 127.7, 128.0, 128.3, 
137.3, 138.7, 147.2, 156.5, 161.7, 219.6; TLC (30:1, H:EA) Rf = 0.25. 
9b (cis isomer): IR (film) 3086, 1708, 1574, 1442 cm'l; iH NMR (300 MHz, 
CDCI3) 6 7.57 (t, J = 7.8 Hz, IH), 7.49-7.25 (m, 6H), 6.67 (d, J = 7.8 Hz, IH), 5.41 
(s, 2H), 4.91 (s, IH), 4.70 (s, IH), 2.91-2.89 (m, IH), 2.70 (m, IH), 2.52-2.42 (m, 
4H), 2.02-1.98 (m, IH), 1.95 (s, 3H), 1.88 (s, 3H), 1.80 (s, 3H), 0.69 (d, J = 7.2 Hz, 
3H); MS (CI, NH3) m/e 396, 442; CMR (CDCI3) b 12.5, 13.2, 22.3, 24.5, 31.1, 
40.0, 40.7, 42.7, 48.0, 67.5, 72.7, 108.4, 112.9,116.7, 127.8, 127.9, 128.3, 137.5, 
138.8, 146.4, 158.8, 161.6, 214.2; TLC (30:1, H:EA) Rf = 0.10. 
2-MethyI-3-[(2-pyridone)methyl]-5-isopropylcyclohexanol (10): 
The sulfide (0.26 mmol) and raney nickel (1 g) were refluxed in 10 mL of 
ethanol for two hours. The crude solution was filtered carefully. The filtrate 
was concentrated in vacuo to afford the pjnridone in 85% yield. The pyridone 
could be purified by flash chromatography on silica gel half saturated with 
ammonia. 
10 (pyridone): IR (film) 3377, 3279, 2957, 2870, 1651, 1616, 1457, 1264, 
1006 cm-1; IH NMR (300 MHz, CDCI3) 8 7.36 (t, J = 6.9 Hz, IH), 6.41 (d, J = 6.9 
Hz, IH), 6.05 (d, J = 6.9 Hz, IH), 3.62-3.55 (m, IH), 2.56-2.45 (m, 2H), 1.93-0.97 
(m, 9H), 0.85 (d, J = 6.3 Hz, 6H), 0.79 (d, J = 6.9 Hz, 3H); MS (CI, NH3) m/e 110, 
127, 248, 264, 281; CMR (CDCI3) S 20.0, 21.2, 30.0, 32.2, 33.3, 34.0, 38.2, 39.0, 
39.9, 41.6, 73.3, 108.1, 117.2, 143.1, 150.0, 166.6; TLC (10:1, EA: MeOH) Rf = 
0.46. 
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l-(6-Chloro-2-methylpyridyl)cyclohex-2-enol: To a solution of LDA, 
freshly prepared from n-BuLi (2.17 M in hexane; 0.74 mL, 1.6 mmol) and N,N-
diisopropylamine (0.16 g, 1.6 mmol) in dry THF (32 mL) was added 6-chloro-2-
picoline at 0 °C (0.20 g, 1.6 mmol). After stirring for 30 minutes, the solution 
was cooled to -78 °C and 2-cyclohexen-l-one (0.15 g, 1.6 mmol) in THF (2 mL) 
was added drop wise. The solution was stirred for two hours and then poured 
into ice water and extracted with diethyl ether (3 X 20 mL). The combined 
extracts were washed with brine and dried over MgS04. The residue was 
purified by silica gel chromatography (hexane: AcOEt, 8:1) to give the allylic 
alcohol in 64% yield. 
IR (film) 3410, 2935, 1587, 1558, 1441, 1171 cm-1; iR NMR (300 MHz, 
CDCI3) 8 7.58 (t, J = 7.8 Hz, IH), 7.21 (d, J = 7.8 Hz, IH), 7.10 (d, J = 7.2 Hz, 
IH), 5.82-5.76 (m, IH), 5.55 (d, J = 9.9 Hz, IH), 4.36 (s, IH), 3.74-3.70 (m, IH), 
3.55-3.15 (m, IH), 2.96 (AB quartet, J = 11.1 Hz, 2H), 2.37-1.18 (m, 4H); MS (EI) 
m/e 79.1, 97.1, 129.0, 177.0, 204.1, 223.1; HRMS (EI) calcd for C12H14CINO 
(M+) 223.0764, found (M+) 223.0760; CMR (CDCI3) 8 18.8, 24.9, 35.8, 47.8, 
69.5, 121.8, 126.1, 129.3, 131.7, 138.8, 149.9, 159.6; TLC ( 5:1 H:EA) Rf = 0.19. 
3-[(6-Chloro-2-pyridyl)bis-(inethylthio)methyl]cyclohexanone: 
To a stirred solution of 4c (200 mg, 0.91 mmol) in THF (8 mL) was added 
n-BuLi (2.22 M in hexane, 0.41 mL, 0.91 mmol) at -78 °C under an Ar atm. 
The mixture was stirred for one hour. Cuprous iodide (87 mg, 0.45 mmol) was 
then added and the mixture stirred for an additional hour at -78 °C. Then, 
2-cyclohexen-l-one (43 mg, 0.45 mmol) in 0.5 mL of THF was added slowly at 
-78 °C and the mixture was stirred at -78 °C for three hours. The reaction 
mixture was quenched by the addition of H2O and allowed to reach room 
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temperature. The precipitate was filtered and the crude mixture was 
extracted with Et20. The extract was washed with brine, dried over MgS04, 
and concentrated to give a residue, which was purified by silica gel 
chromatography (hexane;AcOEt, 25:1) to give the ketone (100% yield). 
IR (film) 2916, 1699, 1574, 1553, 1423, 1136 cm-l; IR NMR (300 MHz, 
CDCI3) 6 7.78 (d, J = 7.8 Hz, IH), 7.66 (t, J = 7.8 Hz, IH ), 7.24 (t, J = 7.8 Hz, 
IH), 2.66-2.08 (m, 5H), 2.04 (s, 3 H), 1.97 (s, 3H), 1.66-1.28 (m, 4H); MS (CI, 
NH3) m/e 268, 316, 333; CMR (CDCI3) 6 13.2, 13.5, 24.8, 27.8, 41.0, 44.3, 47.7, 
71.8, 121.7, 122.9,138.7,150.2,159.9, 210.7; TLC ( 2:1, H:EA) Rf = 0.49. 
2-Methylethanoate-6-chloropyridine (4b): To a solution of 6-chloro-
2-picoline (0.76 g, 6 mmol) in THF (30 mL) at 0° was added n-BuLi (2.35 M in 
hexane, 6.6 mmol, 2.81 mL). The temperature was lowered to -78 °C and 
carbon dioxide was bubbled through the reaction mixture. The mixture was 
allowed to warm to 0 °C and then to room temperature. The mixture was 
quenched by the addition of 0.50 mL of trifluoroacetic acid. The mixture was 
diluted with THF, filtered through a pad of celite, and concentrated. To a 
solution of the crude acid in methylene chloride (0.1 M) was added 4-dimethyl-
aminopyridine (73 mg, 0.6 mmol) and methanol (384 mg, 12 mmol). The 
mixture was cooled to 0 °C and 1,3-dicyclohexylcarbodiimide (1.24 g, 6 mmol) 
in methylene chloride was added. The mixture was stirred for two days at 
room temperature. The residue was purified by silica gel chromatography 
(hexane: AcOEt, 10:1) to give the methyl ester in a 34% overall yield. 
IR (film) 2951, 2254, 1740, 1559, 1471, 1340, 1268 cm-l; IH NMR (330 
MHz, CDCI3) 6 7.63 (t, J = 7.8 Hz, IH); 7.24 (d, J = 7.5 Hz, 2H); 3.88 (s, 2H); 3.72 
(s, 3H); MS (CI, NH3) m/e 186; HRMS (EI) calcd for C8H8CINO2 (M+) 185.0244, 
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found (M+)185.0246; CMR (CDCI3) 6 42.6, 51.7, 122.1, 122.3, 138.8, 150.1, 
154.5, 169.8; TLC ( 4:1, H:EA) Rf = 0.67. 
2-Chloro-6-[bis-(methylthio)methyl]pyridine (4c); To a stirred 
solution of 6-chloro-2-picoline (2 g, 15.7 mmol) in 100 mL of THF was added 
n-BuLi (2.38 M in hexane, 17.3 mmol, 7.3 mL) at 0 °C. The mixture was 
stirred for 30 minutes. The temperature was lowered to -78 °C and dimethyl 
disulfide (1.63 g, 17.3 mmol) was added and the mixture was stirred at -78 °C 
for five hours. The crude mixture was poured into water and extracted with 
ether. The combined extracts were washed with saturated sodium chloride 
and dried over MgS04. The mixture was concentrated in vacuo. To a solution 
of the crude sulfide in THF (100 mL) was added n-BuLi (2.38 M in hexanes, 
17.3 mmol, 7.3 mL) dropwise at 0 °C. The mixture was stirred at 0 °C for 30 
minutes and then the temperature was lowered to -78 °C and dimethyl 
disulfide (1.63 g, 17.3 mmol) was added. The mixture was stirred for five 
hours. The mixture was worked up as described above. The residue was 
purified by silica gel chromatography (30:1, H:EA) to give 4c in 81% overall 
yield. 
IR (film) 3399, 1617, 1558, 1405, 1171 cm-l; iH NMR (300 MHz, CDCI3) 8 
7.66 (t, J = 7.8 Hz, IH), 7.45 (d, J = 7.8 Hz, IH), 7.24 (d, J = 7.8 Hz, IH), 4.85 (s, 
IH), 2.15 (s, 6H); MS (CI, NH3) m/e 141, 220; CMR (CDCI3) 8 14.2, 56.9, 118.7, 
122.7,139.2, 149.8, 159.8; TLC (10:1, H:EA) Rf = 0.50. 
2-Methoxy-6"[bis(methylthio)methyl]pyridine (4d): The bis-sulfide, 
4c, (429 mg., 2.0 mmol,) was heated in a sealed tube in a sodium methoxide 
solution (16 mmol, IM in methanol) for three days at 120 °C. The crude 
mixture was concentrated in vacuo. The crude product was taken up in 
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water and neutralized. Then, the aqueous solution was extracted with 
methylene chloride, and dried over MgS04 to give the pure product in 57% 
yield. 
IR (film) 2978, 1558, 1411, 1313, 1270 cm-1; IR NMR (300 MHz, CDCI3) 6 
7.54 (t, J = 7.8 Hz, IH), 6.95 (d, J = 7.2 Hz, IH), 6.62 (d, J = 8.1 Hz, IH), 4.81 (s, 
IH), 3.93 (s, 3H), 2.17 (s, 6H); MS (CI, NH3) m/e 137, 168, 216; HRMS (EI) calcd 
for C9H13NOS2 (M+) 215.04386, found (M+) 215.04348; CMR (CDCI3) 6 13.7, 
52.8, 57.5, 109.0, 113.4, 138.6, 156.3, 162.8; TLC (20:1, H:EA) Rf = 0.34. 
2-Beiizyloxy-6-[bis-(methyIthio)methyl]pyridine (4e); The bis-
sulfide, 4c, (7.3 mmol, 1.61 g.) was placed in ^e^^-butanol (7.3 mL). Benzyl 
alcohol (1.58 g, 14.6 mmol) and potassium t-butoxide (1.64 g, 14.6 mmol) were 
added and the mixture was heated in a sealed tube at 120 °C for two days. 
The mixture was concentrated in vacuo and the residue was taken up in 
water. The aqueous solution was neutralized by the addition of dilute HCl, 
and extracted with methylene chloride. The combined extracts were 
concentrated in vacuo. The crude product was purified by silica gel 
chromatography (70:1, H;EA) to give the benzyl ether in a 90% overall yield. 
IR (film) 3063, 2914, 1699, 1559, 1456, 1266, 1022 cm-1; IH NMR (300 
MHz, CDCI3) 6 7.56 (t, J = 7.5 Hz, IH), 7.49-7.46 (m, 2H), 7.38-7.29 (m, 3H), 6.96 
(d, J = 7.2 Hz, IH), 6.68 (d, J = 8.4 Hz, IH), 5.38 (s, 2H), 4.81 (s, IH), 2.13 (s, 6H); 
MS (CI, NH3, negative ion) m/e 290; HRMS (EI) calcd for C15H17NOS2 (M+) 
291.0752, found (M+) 291.0755; CMR (CDCI3) 6 14.0, 57.9, 67.4, 109.8, 114.0, 
127.6, 128.0,128.2, 137.2, 139.1, 156.5, 162.6; TLC ( 20:1, H:EA) Rf = 0.40. 
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GENERAL CONCLUSION 
The first section provides an introduction to huperzine A. It details the 
history and isolation of this new natural product. It describes its 
pharmacological properties and its potential therapeutic usage as a 
treatment for cholinergic disorders, such as Alzheimer's disease. Finally, it 
outlines the S3aithetic routes to this alkaloid. This section has shown that 
huperzine A is an interesting synthetic target and has been synthesized in 
moderate yield. 
The first paper describes the use of a bridgehead enone methodology to 
prepare the natural product, huperzine A. By this method, the bicyclic 
framework can be prepared in six steps. Most of the compounds in this 
section were prepared by Jeff Hansen. My contribution involved spectral 
determinations, including 2D NOESY, IR, NMR, and MS. 
The second paper describes a direct route to functionalized pyridones, 
which are structural subunits of huperzine A. By the conjugate addition of 
metallated alkyl pyridines, the s3mthesis of a pyridone compound is 
accomplished in two steps. This research has resulted in the discovery of a 
novel method of 1,4-addition using a side-chain metallated pyridine. 
Throughout my research, I have explored many interesting and 
synthetically challenging routes to analogs of huperzine A. An alternative 
route not reported herein, but noteworthy nonetheless, involved the synthesis 
of the tricyclic core of huperzine A in one step from a functionalized p-keto 
ester (I). The cyclization was first attempted on the bromopyridine (I). The 
compound was reacted with sodium hydride and palladium tetrakistriphenyl-
phosphine. The mechanism is thought to proceed by displacement of the 
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bromide by the palladium to form the heteroaromatic-palladium complex, 
which is subsequently attacked by the nucleophile of the enolate to form the 
cyclized product. However, this did not occur in our case. We obtained the 
product which resulted from retro-aldol cleavage (Scheme I). 
Scheme I 
OEt 
NaH, Pd(PPh3)4 
it 
HO 
OMe 
We next attempted the cyclization on the p-keto ester (II). The compound 
was reacted with manganese (HI) acetate in acetic acid. The mechanism is 
thought to proceed through a manganese enolate which yields an enol 
radical. The radical formed attacks the p3a'idine nucleus to yield a pyridyl 
radical which is oxidized by manganese (III) acetate to the cation. Then, loss 
of a proton yields the pyridine ring. This reaction worked and gave the 
desired tricyclic compound in 50% yield (Scheme II). 
Although this route gave us the tricyclic core to huperzine A, we needed 
a handle to introduce the endocyclic double bond. Furthermore, we were 
unable to improve the yield. Therefore, we focused our efforts on the 
conjugate addition series which would allow functionalization, such as an 
isopropylene moiety in the position of the endocyclic olefin. This would not 
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Scheme II 
H 
Mn(3) •A 
II 
A = COgEt 
only give us a unique analog to huperzine A, but also give us one in which the 
activity might be enhanced due to n:-jt interactions with aromatic residues in 
the active site of acetylcholinesterase. 
For many years organic chemists have discussed and surmounted 
problems such as these. It is only through research involving many hours of 
experimental work that discoveries and insights are obtained. The 
preparation of this dissertation was based on those laborious and gratifying 
hours. 
The future still holds many new strategies and methods of synthesis 
waiting to be discovered. If this work is helpful to fellow chemists in their 
pursuit of new knowledge, the main goal of this dissertation has been 
achieved. 
6 2  
ACKNOWLEDGMENTS 
I am indebted to Dr. George A. Kraus for his guidance and 
encouragement during my tenure as a graduate student. His enthusiasm 
and creativity have been an inspiration to me. From critical discussion to 
"mulling over" ideas, Dr. Kraus has not only been a mentor, but also a fellow 
researcher and friend. He has made my four years at Iowa State extremely 
exciting and enjoyable ones. 
I would also like to thank the members of the Kraus group, past and 
present. I would especially like to thank Brad Andersh, Jackie Applegate, Jeff 
Hansen, and Elaine Kclaczkowski. Most of all, I would like to thank my 
family for their love. In particular, I would like to thank my husband, Paul, 
for the countless tasks he performed for me, from t3T)ing to drawing 
structures. I would like to thank my daughter, Nicole, for her understanding 
and love. I would like to thank my wonderful parents for their support and 
advice, especially when I wanted to come home, and my beloved grandparents, 
Nanny and Papaw, for their constant prayers. Finally and most importantly, 
I would like to thank the Lord God, who makes all things possible. 
